Cision PR Newswire APAC
pressCenter
Exonate Becomes Foventa Therapeuticstranslating…
The new name, which takes inspiration from the fovea, marks the company's transition to focus on clinical development in non-proliferative diabetic retinopathy. In earlier clinical trials, FOV407 exhibited remarkable ability to suppress harmful vascular leakage in patients'…
Keywords#Becomes#Becomes Foventa#Becomes Foventa Therapeutics#Exonate#Exonate Becomes